Sham tVNS
Sham tVNS is a medical device with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression
Vagus Nerve Stimulation and Stress Reduction Training for Migraine
Sympathetic Overactivity in Post-traumatic Stress Disorder
Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib
Transcutaneous Vagus Nerve Stimulation in Heart Failure
Clinical Trials (10)
Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression
Vagus Nerve Stimulation and Stress Reduction Training for Migraine
Sympathetic Overactivity in Post-traumatic Stress Disorder
Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib
Transcutaneous Vagus Nerve Stimulation in Heart Failure
VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment.
TRAnscutaneous vaGUS Nerve Stimulation in Patients With Chronic Heart Failure
Stress and Sleep Study
TMS as a Tool for the Evaluation of Neuromodulatory Effects of Transcutaneous Vagus Nerve Stimulation
tVNS for Cognitive Impairments in Community-Dwelling Elderly
All 10 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 10